# Caladan Bio Inc. — Form D

Caladan Bio Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2024-02-13. The offering totals $5.1M, of which $5.1M was reported sold. Industry: Other Technology.

## Offering

- Filed: 2024-02-13
- Form: D
- Accession: 0001062993-24-002895
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $5.1M
- Amount sold: $5.1M
- Investors: 7
- Date of first sale: 2024-02-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-505078

## Issuer

- Name: Caladan Bio Inc.
- CIK: 0002011857
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 27 W 16TH STREET UNIT 5D, NEW YORK, NY, 10011
- Phone: 847-370-1228

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Robert J Jauquet | Director | Jersey City, NJ |
| Michael J Kobida | Director | New York, NY |
| Robert J Jauquet | Executive Officer | Jersey City, NJ |
| Michael J Kobida | Executive Officer | New York, NY |

## More

- [CIK 2011857 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2011857&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001062993-24-002895.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.